Accelerate Your Oncology Drug Development with Complete DMPK Analysis
Discovering safe and effective pharmaceutical agents demands speed and accuracy. At our state-of-the-art facility, we offer in vivo pharmacokinetic (PK) services that allow you to rapidly assess the pharmaceutical and safety properties of your new agents. Experience the power of TD2’s pharmacological and bioanalytical drug metabolism and pharmacokinetics (DMPK) platform, enabling you to confidently select the most robust drug formulations and optimize your drug discovery and preclinical development strategies.
At TD2, we understand that each drug development journey is unique, and we are committed to tailoring our DMPK panel to match your candidate’s specific requirements. Coupled with our state-of-the-art and AAALAC-accredited vivarium, you can trust that every sample analysis and result is conducted with the utmost precision, accuracy, and reproducibility.
DMPK Available Services:
DMPK: Drug metabolism and pharmacokinetics (DMPK) is a core discipline in drug development that considers the biotransformation of a drug compound and other pharmacokinetic properties to assess drug safety.
- Adherent to FDA guidance for the industry
- Plasma
- Serum
- Tissues including but not limited to:
- Tumor
- Brain
- Heart
- Kidneys
- Lungs
- Muscles
- Drug concentration verification
- Efficacy
- PK
- Plasma
- Microsomal
- Tumor/Tissue
- Hepatic Fractions (S9/Microsomes)
- Hepatocyte
- CYP Phenotyping
- CYP Inhibition
- PAMPA
- Caco-2